When Is the Best Time to Take Urolithin A?

Most clinical trials of urolithin A have administered it in the morning on an empty stomach, and that remains the best-supported timing based on available evidence. But the honest answer is more nuanced than “take it at breakfast,” because the compound’s long half-life, its delayed arrival in muscle tissue, and the emerging science around circadian mitophagy all suggest that the optimal window depends on what you’re trying to get out of it.

What the Clinical Trials Actually Did

The largest and most rigorous human trials of urolithin A have used a consistent protocol: participants took their daily dose first thing in the morning, before eating. In the randomized trial published in JAMA Network Open, older adults took four softgels totaling 1,000 mg of urolithin A each morning on an empty stomach with a glass of water.¹ The ATLAS trial in middle-aged adults used 500 mg and 1,000 mg doses under similar conditions over four months.² An eight-week study in resistance-trained male athletes likewise used 1,000 mg daily.³

These protocols were designed for consistency and reproducibility rather than to test whether morning dosing is superior to evening dosing. No published trial has directly compared the two. So when people say “take it in the morning,” they’re repeating the method researchers happened to use, not a finding that morning is better. That said, following the protocol that actually produced positive results is a reasonable default if you have no other reason to deviate.

How Long It Takes to Reach Your Muscles

Urolithin A is not an instant-acting compound. After you swallow a dose, plasma concentrations peak at roughly six hours. But the compound doesn’t just float around in your blood; it undergoes extensive processing. In circulation, urolithin A appears mostly as glucuronide and sulfate conjugates, which are modified forms the liver creates. The form that actually does the work in muscle tissue is the parent molecule, the unmodified urolithin A, and that shows up in skeletal muscle around eight hours after ingestion, primarily in its monomeric form.⁴

The compound also sticks around for a while. Its half-life runs about 17 to 22 hours, largely because the body recycles it through a loop between the liver and intestines.⁵ This means that with daily dosing, you maintain a fairly steady background level. A single missed dose won’t zero out what’s in your system, and the exact hour you take it matters less than whether you take it consistently.

Timing Around Exercise

If you exercise regularly and want urolithin A available in your muscles when you train, the pharmacokinetics point toward taking it six to eight hours before your workout. That’s the window in which the compound transitions from circulating in the blood to being present in skeletal muscle in its active form. Researchers reviewing the sports nutrition evidence have specifically suggested this pre-exercise window, though they also note that no study has yet tested whether exercise itself changes how urolithin A is absorbed or metabolized.⁴

In practical terms, if you train in the early afternoon, a morning dose lines up well. If you’re an early-morning exerciser, the math gets awkward: you’d need to take it in the middle of the night for it to peak in your muscles by 6 a.m. In that case, a dose the evening before might make more sense, given the long half-life. And if you exercise in the evening, a late-morning dose covers the window. The key point is that urolithin A is not like caffeine, where you feel something within an hour. Its effects build over hours and accumulate over weeks.

The athlete study that found improvements in muscle endurance after eight weeks of daily supplementation didn’t specifically time doses around workouts; participants just took 1,000 mg daily.³ The benefits came from sustained use, not from acute pre-workout timing. So while the six-to-eight-hour window is a reasonable optimization, it’s probably a small edge on top of the much larger effect of just taking it every day.

With Food or Without

The JAMA Network Open trial specified an empty stomach, and that’s the protocol most often cited.¹ But this hasn’t been studied head-to-head against taking it with food. The reasoning behind an empty stomach is straightforward: without competing food in the gut, absorption is more predictable and potentially faster. Many fat-soluble supplements absorb better with food, but urolithin A’s pharmacokinetic profile already shows good bioavailability on an empty stomach, and it doesn’t accumulate in a way that suggests poor absorption.⁵

If taking urolithin A on an empty stomach causes any mild stomach discomfort, taking it with a small meal is unlikely to wreck its effectiveness. Some commercial formulations mix urolithin A into food products like yogurt or soft chews, which obviously means it’s consumed alongside other nutrients. The more important variable is probably consistency rather than fasting status.

Why Consistency Matters More Than the Clock

Urolithin A works by triggering a cellular housekeeping process called mitophagy, where your cells identify damaged mitochondria and break them down so new, functional ones can be built. It activates a specific tagging pathway that marks dysfunctional mitochondria for degradation, while simultaneously stimulating the production of new mitochondria through a separate signaling chain.⁶ This isn’t a one-and-done event. Mitophagy is an ongoing process, and the benefits of urolithin A accrue over weeks to months of regular use.

In the first-in-human safety trial, four weeks of daily dosing at 500 mg or 1,000 mg was enough to shift molecular markers of mitochondrial health in both blood and skeletal muscle.⁷ The ATLAS trial ran four months before measuring improvements in muscle strength and exercise performance.² This is not a supplement where skipping Tuesday and doubling up on Wednesday produces the same outcome. The long half-life helps smooth out minor timing variations, but the sustained signaling that drives mitochondrial turnover requires a steady daily presence.

The Circadian Angle

There’s growing evidence that the body’s internal clock influences mitochondrial maintenance, which makes the timing question more interesting than it might first appear. The circadian clock controls mitochondrial shape, respiratory activity, and energy production, and one of sleep’s functions appears to involve clearing toxic byproducts of cellular metabolism from the brain.⁸ Basal mitophagy itself fluctuates by time of day, with distinct patterns in males and females and significant changes during fasting.⁹

This raises the possibility that a compound designed to boost mitophagy might work differently depending on when the body’s natural mitophagy cycle is peaking or trough. But the research connecting these dots is still in early stages, and no one has tested whether taking urolithin A at night, when certain aspects of mitochondrial cleanup may be elevated, produces better outcomes than morning dosing. The clinical trials that have actually demonstrated benefits in humans all used morning dosing, so the circadian hypothesis, while biologically plausible, remains unproven for this specific supplement.

Urolithin A and Sleep

A recent mini-review explored whether urolithin A might directly affect sleep quality, given its effects on pathways that overlap with sleep biology. The review found no studies that directly measured sleep outcomes after urolithin A supplementation. However, preclinical evidence suggested mechanistic plausibility through pathways such as modulation of the central circadian clock, protection against neuroinflammation caused by sleep deprivation, and effects on the gut microbiome. The authors concluded that studies using actual sleep measurements are still needed before any claims can be made.¹⁰

If you’ve seen marketing claims about urolithin A improving sleep, this is the current state of the evidence: interesting theory, no human data. You shouldn’t choose evening dosing over morning dosing based on sleep-related claims. If anything, the animal research on neuroinflammation and circadian clock modulation suggests a complex relationship that could go either way.¹¹

Why Direct Supplementation Exists in the First Place

Your body can produce urolithin A on its own, but only if you eat foods rich in ellagitannins (like pomegranates, walnuts, and certain berries) and your gut bacteria happen to include the right species to convert those compounds through several chemical steps. Ellagitannins break down into ellagic acid in the stomach and small intestine, and then gut bacteria convert ellagic acid into various urolithins, with urolithin A being the most bioactive.¹² The problem is that people vary enormously in their ability to make this conversion. Some people’s microbiomes produce plenty of urolithin A from a glass of pomegranate juice; others produce very little or none.

Direct supplementation bypasses this lottery entirely. When researchers compared plasma levels after pomegranate juice consumption versus direct urolithin A supplementation, the supplement produced more than six times the exposure.¹³ This is the main reason supplements exist: they deliver a reliable, consistent dose regardless of your individual gut flora. It also means that timing advice based on food-derived urolithin A, which is absorbed very differently and much more unpredictably, doesn’t apply cleanly to supplement users.

What Urolithin A Does Beyond Muscles

Most of the timing conversation revolves around muscle performance, but urolithin A’s effects extend further, and some of these may be less sensitive to precise dosing time. In animal and cell studies, urolithin A strengthened the gut barrier by increasing mucin production in the colon, which thickened the protective mucus layer.¹⁴ It also activated pathways that tighten the junctions between intestinal cells, reducing gut permeability and calming inflammation in models of colitis.¹⁵

For these gut-related effects, the compound’s contact with intestinal tissue during absorption might favor taking it on an empty stomach, when there’s less competition for interaction with the gut lining. But that’s speculative reasoning based on mechanism, not clinical trial data. The brain-related effects, demonstrated in Alzheimer’s disease mouse models where urolithin A reduced the protein plaques associated with the disease and dampened neuroinflammation, operate through entirely different pathways and timelines.¹¹ These effects are far downstream of any single dose and wouldn’t be meaningfully influenced by whether you took your softgel at 7 a.m. or 9 a.m.

Safety and Whether Dose Splitting Makes Sense

Urolithin A has a clean safety record at the doses used in research. A comprehensive toxicology assessment found no changes in blood chemistry, organ function, or any target-organ toxicity even at doses hundreds of times higher than what humans take, with no genotoxicity detected across a battery of tests.¹⁶ Human trials at 500 mg and 1,000 mg daily for up to four months have consistently reported it as well tolerated.⁷

Given the long half-life of 17 to 22 hours, splitting a daily dose into two smaller servings (say, 500 mg morning and 500 mg evening for someone targeting 1,000 mg) would produce a slightly flatter blood level curve throughout the day. Whether this translates to any practical difference is unknown. No trial has compared split versus single dosing. From a pharmacokinetic standpoint, the long half-life means the difference between a once-daily peak-and-trough pattern and a split-dose pattern would be modest. If you find four softgels at once uncomfortable on your stomach, splitting the dose is a reasonable adjustment, but you shouldn’t expect it to meaningfully change efficacy.

Emerging Delivery Formats

Researchers are actively working on improving urolithin A’s bioavailability through novel delivery systems. Liposomal formulations, where urolithin A is enclosed in tiny fat-based bubbles, have shown meaningfully higher absorption in animal studies compared to standard preparations.¹⁷ If these formulations eventually reach the consumer market, they could change the timing calculus. A faster-absorbing formulation would shrink the gap between ingestion and muscle availability, potentially making pre-workout timing more practical. But for now, the softgel and powder formats on the market are what the clinical data is built on, and a six-hour absorption window is what you’re working with.

Some commercial products blend urolithin A into foods like yogurt, protein bars, or drink mixes. These obviously arrive with macronutrients attached, which may modestly slow absorption compared to a fasted-state softgel. Whether this matters for long-term outcomes is unclear, but it does make the “empty stomach” recommendation less absolute than some supplement companies suggest. The overriding pattern across all the data is that the delivery method matters less than the daily habit of taking it at all.

A Practical Framework for Different Schedules

Since no trial has directly compared morning versus evening dosing, and the compound’s long half-life means it lingers in the body for most of the day regardless, here’s how to think about timing based on what we do know:

General health goals: Take your dose whenever you’ll remember to take it every day. Morning on an empty stomach mirrors the clinical trial protocol and is a sensible default.
Afternoon exercisers: A morning dose puts peak muscle availability right around the early-to-mid afternoon, which aligns well with a post-lunch workout.
Morning exercisers: If you train at 6 or 7 a.m., the previous evening’s dose will have been partially processed overnight. Consider an evening dose instead, understanding that you’re departing from the tested protocol but staying within the pharmacokinetic logic.
Evening exercisers: A late-morning or lunchtime dose gives approximately six to eight hours before an evening session.
Sensitive stomachs: Take it with a small amount of food. The slight delay in absorption is unlikely to matter over weeks and months of use.

None of these approaches has been directly validated in a head-to-head trial. All of them rest on extrapolating from pharmacokinetic data and the general principle that consistency over weeks is what drives results. The worst timing for urolithin A is the dose you skip because the “optimal” schedule didn’t fit your life.

1
JAMA Network Open. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
2
PubMed Central. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
3
PubMed Central. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training
4
Frontiers in Nutrition. Emerging evidence of Urolithin A in sports nutrition: bridging preclinical findings to athletic applications
5
Trends in Molecular Medicine. Urolithin A – a natural gut microbiome-derived metabolite with applications for healthy aging
6
Nutrition Research Reviews. Distinct roles of urolithin A and spermidine in mitophagy and autophagy: implications for dietary supplementation
7
Nature Metabolism. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
8
PubMed Central. Mitochondrial autophagy in the sleeping brain
9
Scientific Reports. The interplay between sex, time of day, fasting status, and their impact on cardiac mitochondrial structure, function, and dynamics
10
PubMed Central. Potential impact of urolithin A on pathways relevant to sleep health: a mini review
11
PubMed Central. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
12
PubMed. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation
13
European Journal of Clinical Nutrition. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population
14
Scientific Reports. Urolithin A-mediated augmentation of intestinal barrier function through elevated secretory mucin synthesis
15
PubMed Central. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
16
Food and Chemical Toxicology. Safety assessment of Urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid
17
Elsevier / ScienceDirect. Liposomes encapsulation by pH driven improves the stability, bioaccessibility and bioavailability of urolithin A: A comparative study